Why the study?
Data on the effect of smoking on in-hospital outcomes in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery were limited.
Does smoking affect in-hospital mortality in patients with left ventricular dysfunction undergoing CABG?
Does smoking affect in-hospital mortality in patients with left ventricular dysfunction undergoing CABG?
In a retrospective registry study, current smokers with LV dysfunction undergoing CABG paradoxically had lower in-hospital mortality than non-smokers.
Current smoking was associated with lower in-hospital mortality after CABG in LV dysfunction; leaves open confounding versus paradox, warranting prospective validation.
Background Data on the effect of smoking on In-hospital outcome in patients with left ventricular dysfunction undergoing coronary artery bypass graft (CABG) surgery are limited. We sought to determine the influence of smoking on CABG patients with left ventricular dysfunction. Methods A retrospective study was conducted using data from the China Heart Failure Surgery Registry database. Eligible patients with left ventricular ejection fraction less than 50% underwent isolated CABGS were included. In addition to the use of multivariate regression models, a 1 to 1 propensity scores matched analysis was performed. Our study (n=6,531) consisted of 3,635 smokers and 2896 non-smokers. Smokers were further divided into ex-smokers (n=2373) and current smokers (n=1262). Results The overall in-hospital morality was 3.9%. Interestingly, current smokers have lower in-hospital mortality than non-smokers (2.3% vs 4.9%; adjusted odds ratio [OR], 0.612 [95%CI, 0.395-0.947]). No difference was detected in mortality between ex-smokers and non-smokers (3.6% vs 4.9%; adjusted OR, 0.974 [0.715-1.327]). No significant differences in other clinical end points were observed. Results of propensity-matched analyses were broadly consistent. Conclusions It is paradoxically that current smokers had lower in-hospital mortality than non-smokers. Future studies should be performed to further understand the biological mechanisms that may explain this ‘smoker’s paradox’ phenomenon.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: